To verify the correlation between the AURKB phosphorylation level and resistance to PTX in breast cancer cells, a lentivirus-shRNA vector was used to prepare an MDA-MB-231/PTX-resistant cell line with stable knockdown of AURKB (Fig. 3a, b), i.e., 231/PTX-A. This evidence concerns the gene AURKB and breast carcinoma.